Herpes Simplex Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight 1
DelveInsight Business Research LLP
DelveInsight’s “Herpes Simplex – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the Herpes Simplex market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Herpes Simplex -Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’sHerpes Simplex  – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Herpes Simplex, historical and forecasted epidemiology as well as the  Herpes Simplex  market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. According to an organization’s estimates for 2016 it was found that a total of 491.5 million (95% UI: 430.4 million–610.6 million) individuals 15–49 years of age worldwide were living with HSV type 2 infection (Table 1 and Fig. 2). More women (313.5 million) than men (178.0 million) were infected.

  2. According to study, infections with human herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are common. Among persons aged 14 to 49 years in the United States, the HSV-1 seroprevalence is 47.8%, and the HSV-2 seroprevalence is 11.9%.  Approximately 70% of persons with HIV are HSV-2 seropositive, and 95% are seropositive for either HSV-1 or HSV-2.

  3. According to data, during 2015–2016, prevalence of HSV-1 was 47.8%, and prevalence of HSV-2 was 11.9%. Prevalence of both HSV-1 and HSV-2 increased with age and was higher among females than males.

Key benefits of the report:

1. Herpes Simplex market report covers a descriptive overview and comprehensive insight of the Herpes Simplex  epidemiology and Herpes Simplex market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. The Herpes Simplex market report provides insights on the current and emerging therapies.

3. Herpes Simplex market report provides a global historical and forecasted market covering drug outreach in 7MM.

4. The Herpes Simplex market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Herpes Simplex market.

Request for sample pageshttps://www.delveinsight.com/sample-request/herpes-simplex-market

Herpes Simplex: Overview

Herpes simplex is a viral infection caused by the herpes simplex virus. Infections are categorized based on the part of the body infected. Oral herpes involves the face or mouth. It may result in small blisters in groups often called cold sores or fever blisters or may just cause a sore throat.

The key players involved in the Herpes Simplex market:

  1. AiCuris Anti-infective Cures

  2. Heidelberg Immuno Therapeutics 

  3. United BioPharma

The launch of the emerging therapies is expected to significantly impact the Herpes Simplex treatment scenario in the upcoming years:-

Drug covered

  1. Pritelivir

  2. HDIT101

  3. UB-621

Request a free sample report @https://www.delveinsight.com/sample-request/herpes-simplex-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Herpes Simplex Patient Share (%) Overview at a Glance

5. Herpes Simplex Market Overview at a Glance

6. Herpes Simplex Disease Background and Overview

7. Herpes Simplex Epidemiology and Patient Population

8. Country-Specific Patient Population of Herpes Simplex 

9. Herpes Simplex Current Treatment and Medical Practices

10. Unmet Needs

11. Herpes Simplex Emerging Therapies

12. Herpes Simplex Market Outlook

13. Country-Wise Herpes Simplex Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Herpes Simplex Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Herpes Simplex- Pipeline Insights, 2021

Herpes Simplex- Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Herpes Simplex market. A detailed picture of the Herpes Simplex pipeline landscape is provided, which includes the disease overview and Herpes Simplex treatment guidelines.

Herpes Simplex -Epidemiology Forecast to 2030

DelveInsight’s ‘Herpes Simplex – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Herpes Simplex{;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/